Follow-The-Filings

Security · featured owners

DNTH Dianthus Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 32.9%
  • $206M
  • 1 add 1 exit

DNTH (Dianthus Therapeutics Inc.) is held in 2 featured 13F books as of 2026 Q2. David Witzke - Avidity Partners Management is the largest tracked holder by portfolio weight (32.8%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 32.9% (David Witzke - Avidity Partners Management) · not free-float ownership

  1. David Witzke 32.9%
  2. Polen Capital Management add 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management 2026 Q2 32.9% Hold 2,104,184 $205M history
Polen Capital Management 2026 Q2 0.01% Add +126.6% 9,333 $910K history
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0.40% Exit −0.40% 836,000 $70M history

2 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc
424B5 Filing Doc
8-K 2.02,7.01,8.01 Filing Doc
10-K Filing Doc
424B5 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 19, 2026 Filing Doc
4 Period Aug 13, 2026 Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Aug 10, 2026 · 2 forms Filing Doc
4 Period Aug 7, 2026 Filing Doc
4 Period Jul 9, 2026 Filing Doc
4 Period Jun 17, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 21, 2026 · 7 forms Filing Doc
4 Period May 8, 2026 Filing Doc
4 Period Apr 9, 2026 Filing Doc
4 Period Mar 31, 2026 · 2 forms Filing Doc
4 Period Mar 24, 2026 Filing Doc
4 Period Mar 16, 2026 Filing Doc
4 Period Mar 12, 2026 · 2 forms Filing Doc

Updated 5 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — $6.24M $2.04M
Net income -$43.56M -$84.97M -$162.34M
Net margin * — -1362.8% -7973.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $177.45M $280.9M $409.44M
Total non-current assets * $1.95M $93.1M $121.48M
Total assets $179.4M $374.01M $530.92M
Total current liabilities $9.63M $18.45M $30.73M
Total non-current liabilities * $0.904M $3.08M $6.79M
Total equity $168.87M $352.48M $493.4M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$36.86M -$78.18M -$129.06M
Cash from investing $20.25M -$286.81M -$122.83M
Cash from financing $133.57M $255.62M $280.12M
Net change in cash $116.97M -$109.37M $28.23M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders